Какова цена за Roche Holding AG (RO)

Цена за Roche Holding AG (RO) Это $484.33

Какова рыночная капитализация для Roche Holding AG (RO)

Рыночная капитализация для Roche Holding AG (RO) Это $379.69B

Доходы Roche Holding AG (RO)

Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.

Год	Выручка	Изменить
2026 (TTM)	$77.52B	12.54%
2021	$68.88B	4.53%
2019	$65.90B	0.00%

Год

Выручка

Изменить

2026 (TTM)

$77.52B

12.54%

2021

$68.88B

4.53%

2019

$65.90B

0.00%

Компания	Выручка	Разница в выручке	Страна
Eli Lilly and Company LLY.US	$79.67B	2.77%	US
Johnson & Johnson JNJ.US	$97.93B	26.33%	US
AbbVie Inc. ABBV.US	$64.39B	-16.94%	US
Merck & Co., Inc. MRK.US	$66.40B	-14.34%	US
Novartis AG NOVN.SW	$56.26B	-27.43%	CH

Компания

Выручка

Разница в выручке

Страна